Firefly Neuroscience AIFF
NASDAQ AIFF
$1.13 +0.03 (+2.73%)
At close: Sep 4, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) Income from Continuing Operations (2010 - 2026)

Firefly Neuroscience (AIFF) posted Income from Continuing Operations of -$2.0 million for Q2 2026, up 1.0% on a QoQ basis from -$2.0 million in Q1 2026, and down 8.24% year-over-year from -$2.2 million in Q2 2025.

Analysis

Firefly Neuroscience (AIFF) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Firefly Neuroscience has reported Income from Continuing Operations for 16 years, with the latest figure at -$2.0 million in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations fell 8.24% year-over-year to -$2.0 million in Q2 2026; TTM through Jun 2026 was -$4.9 million, a 79.31% increase from a year earlier, with the FY2025 full-year figure at -$15.7 million, down 90.09% from the prior year.
  • Income from Continuing Operations was -$2.0 million for Q2 2026 at Firefly Neuroscience, up from -$2.0 million in the prior quarter.
  • The five-year high for Income from Continuing Operations was $1.7 million in Q4 2025, with the low at -$12.9 million in Q1 2025.
  • Average Income from Continuing Operations over 5 years is -$2.1 million, with a median of -$1.8 million recorded in 2025.
  • The largest YoY upside for Income from Continuing Operations was 167.54% in 2022 against a maximum downside of 4553.26% in 2022.
  • Over 5 years, Income from Continuing Operations stood at $911778.0 in 2022, then sank by 139.26% to -$358000.0 in 2023, then sank by 1764.53% to -$6.7 million in 2024, then jumped by 125.45% to $1.7 million in 2025, then tumbled by 216.77% to -$2.0 million in 2026.
  • The last three Income from Continuing Operations figures came in at -$2.0 million (Q2 2026), -$2.0 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn 574.00 Mn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn 75.03 Mn
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn -15.74 Mn
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn -10.50 Mn
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn -12.91 Mn
6 QuidelOrtho 954.15 Mn 830.75 Mn - -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn -19.27 Mn
8 Anbio Biotechnology 941.05 Mn 929.15 Mn - -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn 15.90 Mn
10 Firefly Neuroscience 23.25 Mn 14.03 Mn 253,000.00 -1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.98 Mn
Mar 31, 2026 -2.00 Mn
Dec 31, 2025 1.70 Mn
Sep 30, 2025 -2.64 Mn
Jun 30, 2025 -1.83 Mn
Mar 31, 2025 -12.93 Mn
Sep 30, 2024 -6.68 Mn
Jun 30, 2024 -2.39 Mn
Mar 31, 2024 -1.12 Mn
Dec 31, 2023 -358,000.00
Sep 30, 2023 -650,000.00
Jun 30, 2023 456,438.00
Mar 31, 2023 -990,087.00
Dec 31, 2022 911,778.00
Sep 30, 2022 -1.17 Mn
Jun 30, 2022 -1.92 Mn
Mar 31, 2022 -2.16 Mn
Dec 31, 2021 -1.35 Mn
Sep 30, 2021 -95,527.00
Jun 30, 2021 43,157.00